HR 2846 · 117th Congress 2021โ€“2023, ended

Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021

Latest action · Apr 27, 2021 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 26, 2021
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021

This bill establishes additional requirements for prescription drug plan (PDP) sponsors that use formularies under the Medicare prescription drug benefit.

Specifically, the bill requires PDP formularies to include covered generic drugs and biosimilars for which the wholesale acquisition cost is less than that of the reference (i.e., brand-name) product. PDP sponsors must also establish specific cost-sharing tiers that apply lower cost-sharing requirements for such covered generic drugs and biosimilars as compared to those for brand-name products.

The bill also prohibits PDP sponsors from instituting certain requirements relating to access to such covered generic drugs and biosimilars that are more restrictive than those for brand-name products (e.g., prior authorization requirements).

Cosponsors 10

Members who signed on, in the order they did. Signatures ran from Apr 26, 2021 to Jul 1, 2021; 5 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-NHAnn M. KusterOriginalApr 26, 2021
D-CADoris O. MatsuiOriginalApr 26, 2021
R-GAEarl L. "Buddy" CarterOriginalApr 26, 2021
D-CAKaren BassOriginalApr 26, 2021
D-NYPaul TonkoOriginalApr 26, 2021
D-FLDarren SotoApr 30, 2021
D-ILRobin L. KellyMay 25, 2021
D-VTPeter WelchJun 8, 2021
D-MNAngie CraigJun 22, 2021
R-WIGlenn GrothmanJul 1, 2021

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Apr 26, 2021
Health Subcommittee
Referred Apr 27, 2021
HouseWays and Means Committee
Referred Apr 26, 2021
Health Subcommittee
Referred Apr 26, 2021
Social Security Subcommittee
Referred Apr 26, 2021

Actions 5

Everything that happened, newest first.

  1. Apr 27, 2021Referred to the Subcommittee on Health.
  2. Apr 26, 2021Introduced in House
  3. Apr 26, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Apr 26, 2021Referred to the Subcommittee on Health.
  5. Apr 26, 2021Referred to the Subcommittee on Social Security.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: To make all Laws which shall be necessary and proper for carrying into Execution the foregoing Powers, and all other Powers vested by this Constitution in the Government of the United States, or any Department or Officer thereof

The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 71, April 26, 2021, page H2115.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 117-809PRESCRIPTION DRUG PRICE INFLATION: AN URGENT NEED TO LOWER DRUG PRICES IN MEDICARE224 pagesFinance CommitteeMar 16, 2022
Serial No. 117-27NEGOTIATING A BETTER DEAL: LEGISLATION TO LOWER THE COST OF PRESCRIPTION DRUGS139 pagesEnergy and Commerce CommitteeMay 4, 2021

Related bills 1

Companion bills and other measures the record links to this one.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes.
Short Title(s) as Introduced
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Apr 26, 2021Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.